Trial record 1 of 13 for:
Open Studies | "Thiamine"
Does Thiamine Help Vomiting and Nausea in Pregnancy?
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by HaEmek Medical Center, Israel.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
HaEmek Medical Center, Israel
Information provided by:
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT00861523
First received: February 18, 2009
Last updated: May 31, 2010
Last verified: May 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
There are different treatments for nausea and vomiting in pregnancy. According to the ACOG recommendations, promethazine is the first line of parenteral treatment after oral treatment had failed. Thiamine is given to prevent wernicke encephalopathy. This research try to find out whether thiamine helps the vomiting and nausea as well, by comparing the response to thiamine and promethazine in women who suffer from nausea and vomiting in pregnancy.
| Condition | Intervention | Phase |
|---|---|---|
|
Hyperemesis Gravidarum |
Drug: thiamine & promethazine |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Comparison Between the Treatment of Thiamine and Promethazine for Improving Vomiting and Nausea in Pregnancy |
Resource links provided by NLM:
MedlinePlus related topics:
Nausea and Vomiting
Drug Information available for:
Promethazine hydrochloride
Diphenhydramine
Thiamine
Promethazine
Thiamine hydrochloride
Diphenhydramine hydrochloride
Thiamine mononitrate
Diphenhydramine citrate
U.S. FDA Resources
Further study details as provided by HaEmek Medical Center, Israel:
Primary Outcome Measures:
- the improvement in nausea and/or vomiting after treatment [ Time Frame: 2 months after first visit in ER (until 14 week of pregnancy) ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 280 |
| Study Start Date: | February 2009 |
| Estimated Primary Completion Date: | April 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1. thiamine
Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive thiamine IV
|
Drug: thiamine & promethazine
thiamine 100 mg IV promethazine 25 mg IV
|
|
Active Comparator: 2. promethazine
Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive promethazine IV
|
Drug: thiamine & promethazine
thiamine 100 mg IV promethazine 25 mg IV
|
Detailed Description:
- Research groups: pregnant women eho visit the emergency room for nausea and vomiting in pregnancy, pregnancy age 12 weeks or less
- After basic examinations and hydration, the women will randomized to thiamine or promethazine treatment.
- If no improvement is shown, the patient will be treated with the other drug
- The patients will be interviewed on their current visit and every two weeks until 14th week of gestation
- The interview includes medical history and details about their illness, other treatments, hospitalization etc.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Pregnant women until 12th week of gestation
- The women visit the ER because of nausea and vomiting
- The women didn't received thiamine yet
Exclusion Criteria:
- Pregnant women over 12th week of gestation
- Women that received thiamine before
- women that allergic to the studied drugs
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00861523
Contacts
| Contact: Yfat Kadan, MD | 972-4-6494331 | yfat_ka@bclalit.org.il; kadana@bezeqint.net |
Locations
| Israel | |
| Gynecologic department, Haemek medical center | Recruiting |
| Afula, Israel | |
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
| Principal Investigator: | Yfat Kadan | Haemek medical center |
More Information
No publications provided
| Responsible Party: | Dep. of OB/GYN, HaEmek Medical Center, yfat kadan |
| ClinicalTrials.gov Identifier: | NCT00861523 History of Changes |
| Other Study ID Numbers: | 0101-08-EMC |
| Study First Received: | February 18, 2009 |
| Last Updated: | May 31, 2010 |
| Health Authority: | israel: helsinky comittee |
Keywords provided by HaEmek Medical Center, Israel:
|
nausea vomiting pregnancy |
thiamine promethazine nausea and vomiting in pregnancy |
Additional relevant MeSH terms:
|
Thiamine Hyperemesis Gravidarum Nausea Vomiting Morning Sickness Pregnancy Complications Signs and Symptoms, Digestive Signs and Symptoms Promethazine Diphenhydramine Antipruritics Dermatologic Agents Therapeutic Uses Pharmacologic Actions Histamine H1 Antagonists |
Histamine Antagonists Histamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Anti-Allergic Agents Antiemetics Autonomic Agents Peripheral Nervous System Agents Central Nervous System Agents Gastrointestinal Agents Hypnotics and Sedatives Central Nervous System Depressants Anesthetics, Local Anesthetics |
ClinicalTrials.gov processed this record on May 19, 2013